Enhanced Controlled Substance Ordering System to Launch December 9, 2024

December 4, 2024

The updated Controlled Substance Ordering System (CSOS) will provide increased security without impacting customer service or patients’ access to medications.

The system – used by DEA-registered pharmaceutical drug manufacturers and distributors, pharmacies, hospitals, and others – allows for the electronic ordering of Schedule I through V controlled substances.

An estimated 190,000 of DEA’s more than 2.1 million registrants utilize CSOS. Learn more about the new, enhanced CSOS program and upcoming training opportunities.